|
E.V. Rebrova, E.V. Shikh
Assessment of the effect of minimum steady-state concentrations of angiotensin II receptor blockers on the dynamics of office blood pressure values in patients with newly diagnosed stage 1–2 arterial hypertension
|
№1 / 2025
|
|
E.V. Rebrova, E.V. Shikh, S.A. Solovieva, G.G. Melkonyan, N.P. Kulagina
Analysis of associations of polymorphic markers of the CYP2C9, AGTR1, AGT, ACE, CYP11B2 genes with the achievement of target blood pressure values in patients with newly diagnosed arterial hypertension 1-2 degree after 3 weeks of pharmacotherapy with angiotensin II receptor blockers
|
№9 / 2024
|
|
A.E. Bagriy (1), E.S. Mikhailichenko (2), L.I. Kardashevskaya (1), E.V. Shchukina (1)
Potentials for dual RAAS blockade in the correction of endothelial dysfunction in hypertensive patients: comparative study
|
№9 / 2019
|
|
E.I. Astashkin, M.G. Glezer
ROLE OF DIFFERENT TYPES OF RENIN-ANGIOTENSIN SYSTEM IN PATHOGENESIS OF CARDIOVASCULAR DISEASES. FOCUS ON VALSARTAN
|
№13 / 2014
|
|
I.Ye. Chazova, V.V. Fomin, M.A. Razuvaeva
Resistant And Uncontrolled Arterial Hypertension: Problem Of Xxi Century
|
№5 / 2011
|
Русский
